Dental Biomaterials Market is Analytically Rising at a Healthy CAGR of 6.2% During Forecast 2018-2023

Analysis

Market Dynamics:

Another beneficial factor for market growth is the rise in marketing strategies by players, including acquisitions that help them expand their product and service platform. With the acquisition of significant regional players by international companies, the dental industry has become more consolidated. Citing a reference, Straumann Holding AG, since 2014, has made three acquisitions in Brazil and Asia. In 2015, the company took possession of Neodent S.A., a prominent company in Brazil. The same year, Dentsply merged with Sirona Dental Systems, which turned out to be one of the biggest merger activities within the dental industry. The merger helped combined dental and consumable technology businesses of both the companies.

Various factors are propelling the dental biomaterials market growth. Such factors, as per the latest Market Research Future report, include the growing awareness about the significance of dental implants, rise in disposable income, rising investments in the dental industry, and growing dental tourism. Additional factors pushing the growth of the dental biomaterials market include increasing dental expenditure and increasing incidence of dental trauma and dental caries.

Market Research Future (MRFR) says that the global Dental Biomaterials Market Growth could achieve a CAGR of 6.2% during the forecast period (2018-2023).

Growth Boosters and Top Challenges:

The quickly increasing number of qualified dental professionals could elevate access to dental care. Recent statistics released by the Brazilian Institute of Geography and Statistics (IBGE) states that the country has about 174,000 dentists, which translates to 11% of the total number in the world. Following the implementation of the Oral Health National Policy in Brazil since 2004, there has been a rise in population that is more aware of oral health.

Prominent Companies

·         Dentsply Sirona

·         Geistlich Pharma AG

·         Zimmer Biomet Holdings

·         3M Company

·         Straumann Holding AG

·         Carpenter Technology Corporation

·         Kuraray Co

·         Medtronic PLC

·         Henry Schein